Insomnia
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Chinese aged 12-18 years old; 2. Written informed consent of participation into the study is given by his/her parents or caregivers; 3. Being able to comply with the study protocol; 4. Having at least one of the biological parents (either mother or father) reporting lifetime history or current insomnia disorder as defined by DSM-V (Having >/= 3 times of DIS, DMS, or EMA for 3 months, with significant distress or impairment of daytime functioning; 5. Reporting sub-threshold insomnia symptoms [having sleep difficulty in one of the following domains at least once per month but less than three times per week in the past one month: DIS, DMS, or EMA].
Exclusion criteria
Exclusion criteria: 1. A current or past history of psychiatric disorder(s) or neurodevelopmental disorder(s); 2. Receiving a medication known to affect sleep continuity and quality (e.g. psychotropics); 3. Having a prominent medical condition known to interfere with sleep continuity and quality(e.g. Eczema, Gastric acid reflux); 4. Having a clinically diagnosed sleep disorder that may potentially contribute to a disruption in sleep continuity and quality, such as narcolepsy, sleep-disordered breathing, and restless leg syndrome, as ascertained by the Structured Diagnostic Interview for Sleep Patterns and Disorders (DISP).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Incidence of insomnia disorder as confirmed by a clinical diagnosis of insomnia disorder based on DSM-V criteria;2. The severity of insomnia symptoms as measured by Insomnia Severity Index (ISI) All primary outcomes will be measured at baseline and reassessed at 2-week, 6-month, 12 month, and 18 month after the interventional trial.; | — |
Secondary
| Measure | Time frame |
|---|---|
| PDSS (daytime sleepiness scale);DBAS(sleep belief);FIRST(vulnerability to stress-related insomnia);ASHS(Adolescent Sleep Hygiene Practice);MEQ(Morningness and eveningness questionnaire);sleep diary;actiwatch and salivary cortisol;Mental health and fatigue will be measured by HADS, MFI and Kidscreen-27.; | — |
Countries
China